PathogenDx
Headquartered in Scottsdale, Arizona, PathogenDx's mission is to become the new standard in DNA-based testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries. PathogenDx's technology can rapidly identify and detect up to 50 pathogens all in a single test, in six hours providing triplicate data per analyte for certainty in results with a simple and easy process. The company's DNA-testing products - Detectx™, Quantx™ and Envirox™ are disrupting the century old practice of petri dish testing to identify, detect and quantify pathogens that threaten human health, our ecosystem and the environment. This technology will help growing businesses deliver safer products leading to healthier lives, while preventing billions of dollars in losses from infection and contamination.
About PathogenDx
Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$12MCategory
Industry
BiotechnologyLocation
City
TucsonState
ArizonaCountry
United StatesPathogenDx
Find your buyer within PathogenDx